Status:
ACTIVE_NOT_RECRUITING
Effectiveness of Gradual Versus Rapid Weight Loss
Lead Sponsor:
The Hospital of Vestfold
Collaborating Sponsors:
Roede AS
Conditions:
Obesity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This randomized controlled trial aims to compare the 1-year effectiveness of an initial rapid weight loss (RWL) program and a gradual weight loss (GWL) program.
Detailed Description
A total of at least 286 participants will be randomized to either a 16-week rapid weight loss (RWL) program; \[an 8-week low-energy-diet (\<1000 kcal/day) - followed by an 8-week gradual increase in e...
Eligibility Criteria
Inclusion
- • Willing and able to give informed consent for participation in the study
- Living in the eastern part of Norway, mainly Oslo, Buskerud, Vestfold and Akershus
- Understanding Norwegian language written and spoken easily
- BMI ≥30.0 kg/m2
- Stable body weight (\<5 kg self-reported weight change) during the last 3 months before inclusion
Exclusion
- • Pregnancy and breast-feeding mothers
- Suspected non-compliance with regards to visits and/or diet
- Severe chronic disease (endocrine disease, heart disease, neurological disease, lung disease, disease in the gastrointestinal tract, kidney disease, rheumatism or cancer).
Key Trial Info
Start Date :
April 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2028
Estimated Enrollment :
293 Patients enrolled
Trial Details
Trial ID
NCT03776552
Start Date
April 11 2019
End Date
December 31 2028
Last Update
June 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vestfold Hospital Trust
Tønsberg, Norway